(Press-News.org) Fairfax, Va., April 3, 2014—Dose-escalated intensity modulated radiation therapy (IMRT) with use of a moderate hypofractionation regimen (72 Gy in 2.4 Gy fractions) can safely treat patients with localized prostate cancer with limited grade 2 or 3 late toxicity, according to a study published in the April 1, 2014 edition of the International Journal of Radiation Oncology · Biology · Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
Previous randomized clinical trials have shown that dose-escalated radiation therapy improves prostate cancer control compared to lower-dose conventional radiation therapy. Conventional fractionation of dose-escalated radiation therapy (1.8 or 2 Gy fractions) can take up to nine weeks to complete, while hypofractionated radiation therapy can deliver a higher biologically effective dose over a shorter period of time (six weeks) and has the potential to increase prostate cancer control without increasing toxicity. However, there are limited data on the late toxicity of moderate hypofractionated regimens for prostate cancer. This randomized trial from the University of Texas MD Anderson Cancer Center compares the late toxicity outcomes of men with localized prostate cancer treated with either conventionally fractionated IMRT (CIMRT) or dose-escalated hypofractionated IMRT (HIMRT).
Men with organ-confined prostate cancer were enrolled in this institutional review board-approved trial from January 2001 to January 2010 and were randomized to receive either CIMRT (75.6 Gy in 1.8 Gy fractions over eight-and-a-half weeks) or HIMRT (72 Gy in 2.4 Gy fractions over six weeks). Eligible patients had biopsy-proven prostate adenocarcinoma; good performance status; stage T1b-T3b disease; a prostate-specific antigen (PSA) ≤20 ng/ml; a Gleason score <10; and no clinical, radiographic or pathologic evidence of nodal or bone metastasis. Patients with stage cT3c or cT4 disease, a history of prior pelvic radiation therapy, or who received more than four months of hormone ablation therapy with prior or planned radical prostate surgery and with concurrent active malignancy other than nonmetastatic skin cancer or early-stage chronic lymphocytic leukemia were not eligible for the trial. The median age of the patient cohort was 68. Of the 203 patients analyzed in the study, 72 percent had stage T1 disease (146) and 89 percent had a PSA <10 ng/ml (181). Thirty-four percent (70) had Gleason 6 disease, 65 percent (131) had Gleason 7 disease and 1 percent (2) had Gleason 8 disease. Patients were classified into low-risk (28 percent = 57), intermediate risk (71 percent = 144) and high-risk (1 percent = 2) disease using current National Comprehensive Cancer Network risk-group definitions.
All patients were treated with static-field IMRT. One hundred and one (101) men received CIMRT and 102 men received HIMRT. Physician-reported toxicity was evaluated for all patients during treatment and at each follow-up visit. After completion of radiation therapy, follow-up was conducted at least every six months for the first two years post-treatment, and annually thereafter. Median follow-up was six years.
Late gastrointestinal (GI) and genitourinary (GU) toxicity were analyzed in this study, starting 90 days post-treatment, using modified Radiation Therapy Oncology Group toxicity grading. In the CIMRT arm, 17 percent (17) experienced grade 1 GI toxicity, 4 percent (4) experienced grade 2 GI toxicity and 1 percent (1) experienced grade 3 GI toxicity. In the HIMRT arm, 26 percent (27) experienced grade 1 GI toxicity, 9 percent (9) experienced grade 2 GI toxicity and 2 percent (2) experienced grade 3 GI toxicity. There was a numeric increase in the absolute frequency of late GI toxicity for men treated with HIMRT, but the difference was not statistically significant. The five-year actuarial grade 2 or 3 late GI toxicity was 5.1 percent (95 percent Confidence Interval (CI)) for patients treated with CIMRT and 10 percent for patients treated with HIMRT. The increase in late GI toxicity for men receiving HIMRT was the result of moderate and high radiation dose to a larger proportion of the rectum, which suggests that more stringent dose constraints for the rectum may result in lower late GI toxicity for those patients.
Additionally, there was not a statistically significant difference in the absolute frequency of late GU toxicity in men treated with CIMRT or HIMRT. In the CIMRT arm, 15 percent (15) experienced grade 1 GU toxicity, 14 percent (14) experienced grade 2 GU toxicity and 1 percent (1) experienced grade 3 GU toxicity. In the HIMRT arm, 10 percent (10) experienced grade 1 GU toxicity and 15 percent (15) experienced grade 2 GU toxicity; no patients reported grade 3 GU toxicity. The five-year actuarial grade 2 or 3 late GU toxicity was 16.5 percent (95 percent CI) for patients treated with CIMRT and 15.8 percent for patients treated with HIMRT.
"These results demonstrate that the length of radiation treatment for prostate cancer can be safely decreased to six weeks (from eight-and-a-half weeks) by delivering larger daily doses of radiation without increasing the urinary and bowel effects," said Karen E. Hoffman, MD, a co-author of the study and assistant professor in the Division of Radiation Oncology at the University of Texas MD Anderson Cancer Center in Houston. "Decreasing the length of treatment decreases the cost and is more convenient for patients."
INFORMATION:
For a copy of the manuscript of the study, contact Brittany Ashcroft at 703-839-7336, press@astro.org. For more information about the Red Journal, visit http://www.redjournal.org.
ABOUT ASTRO
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology · Biology · Physics and Practical Radiation Oncology; developed and maintains an extensive patient website, http://www.rtanswers.org; and created the Radiation Oncology Institute, a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit http://www.astro.org.
Dose-escalated hypofractionated IMRT, conventional IMRT for prostate cancer have like side effects
2014-04-03
ELSE PRESS RELEASES FROM THIS DATE:
Fences cause 'ecological meltdown'
2014-04-03
NEW YORK (Embargoed – Not for release until 14:00 EST 3 April 2014) Wildlife fences are constructed for a variety of reasons including to prevent the spread of diseases, protect wildlife from poachers, and to help manage small populations of threatened species. Human–wildlife conflict is another common reason for building fences: Wildlife can damage valuable livestock, crops, or infrastructure, some species carry diseases of agricultural concern, and a few threaten human lives. At the same time, people kill wild animals for food, trade, or to defend lives or property, and ...
Quantum photon properties revealed in another particle -- the plasmon
2014-04-03
For years, researchers have been interested in developing quantum computers—the theoretical next generation of technology that will outperform conventional computers. Instead of holding data in bits, the digital units used by computers today, quantum computers store information in units called "qubits." One approach for computing with qubits relies on the creation of two single photons that interfere with one another in a device called a waveguide. Results from a recent applied science study at Caltech support the idea that waveguides coupled with another quantum particle—the ...
NIST launches a new US time standard: NIST-F2 atomic clock
2014-04-03
The U.S. Department of Commerce's National Institute of Standards and Technology (NIST) has officially launched a new atomic clock, called NIST-F2, to serve as a new U.S. civilian time and frequency standard, along with the current NIST-F1 standard.
NIST-F2 would neither gain nor lose one second in about 300 million years, making it about three times as accurate as NIST-F1, which has served as the standard since 1999. Both clocks use a "fountain" of cesium atoms to determine the exact length of a second.
NIST scientists recently reported the first official performance ...
Taming a poison: Saving plants from cyanide with carbon dioxide
2014-04-03
The scientific world is one step closer to understanding how nature uses carbon-capture to tame poisons, thanks to a recent discovery of cyanoformate by researchers at Saint Mary's University (Halifax, Canada) and the University of Jyväskylä (Finland). This simple ion — which is formed when cyanide bonds to carbon dioxide — is a by-product of the fruit-ripening process that has evaded detection for decades.
Chemists have long understood the roles presence of cyanide (CN−) and carbon dioxide (CO2) in fruit ripening, but have always observed them independently. This ...
Hot mantle drives elevation, volcanism along mid-ocean ridges
2014-04-03
PROVIDENCE, R.I. [Brown University] — Scientists have shown that temperature differences deep within Earth's mantle control the elevation and volcanic activity along mid-ocean ridges, the colossal mountain ranges that line the ocean floor. The findings, published April 4 in the journal Science, shed new light on how temperature in the depths of the mantle influences the contours of the Earth's crust.
Mid-ocean ridges form at the boundaries between tectonic plates, circling the globe like seams on a baseball. As the plates move apart, magma from deep within the Earth rises ...
HIV vaccine research must consider various immune responses
2014-04-03
WHAT:Last year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, held a scientific meeting to examine why certain investigational HIV vaccines may have increased susceptibility to HIV infection. In a new perspectives article appearing in the journal Science, HIV research leaders from NIAID (Anthony S. Fauci, M.D., and Carl W. Dieffenbach, Ph.D.) and its grantees at Emory University (Eric Hunter, Ph.D.) and the University of California, San Francisco (Susan Buchbinder, M.D.), summarize the findings and considerations ...
Moving the fence posts
2014-04-03
The use of fenced areas to protect threatened species in the wild should be a last resort, argue scientists from the Zoological Society of London (ZSL) and the Wildlife Conservation Society (WCS).
In an article published in the journal Science, the authors state that there is a need to review the use of fencing as the conservation community develops a clearer understanding of the ecological changes caused when an area is fenced.
Fencing can have a disruptive impact on predator-prey dynamics, with species such as the African wild dog learning to chase prey into fences. ...
Researchers design trees that make it easier to produce paper
2014-04-03
Researchers have genetically engineered trees that will be easier to break down to produce paper and biofuel, a breakthrough that will mean using fewer chemicals, less energy and creating fewer environmental pollutants.
"One of the largest impediments for the pulp and paper industry as well as the emerging biofuel industry is a polymer found in wood known as lignin," says Shawn Mansfield, a professor of Wood Science at the University of British Columbia.
Lignin makes up a substantial portion of the cell wall of most plants and is a processing impediment for pulp, ...
Cassini reports sub-surface ocean on Enceladus
2014-04-03
Enceladus—one of Saturn's smaller satellites—has joined the ranks of Titan and Europa as a moon that appears to have liquid water splashing around inside of it, researchers say. New gravity data from the Cassini spacecraft, which has been exploring the planet's moons for 10 years, reveal that Enceladus harbors an ocean of water beneath 18 to 24 miles (30 to 40 kilometers) of ice at its surface.
A team of Italian and American scientists led by Luciano Iess at Sapienza Università di Roma in Rome, Italy investigated the moon's gravity field and the notable asymmetry it ...
Gravity measurements confirm subsurface ocean on Enceladus
2014-04-03
In 2005, NASA's Cassini spacecraft sent pictures back to Earth depicting an icy Saturnian moon spewing water vapor and ice from fractures, known as "tiger stripes," in its frozen surface. It was big news that tiny Enceladus—a mere 500 kilometers in diameter—was such an active place. Since then, scientists have hypothesized that a large reservoir of water lies beneath that icy surface, possibly fueling the plumes. Now, using gravity measurements collected by Cassini, scientists have confirmed that Enceladus does in fact harbor a large subsurface ocean near its south pole, ...